Literature DB >> 21604320

Prognostic value of fluorine-18 fluorodeoxyglucose positron-emission tomography imaging in patients with head and neck squamous cell carcinoma.

Solène Querellou1, Ronan Abgral, Pierre-Yves Le Roux, Emmanuel Nowak, Gérald Valette, Gaël Potard, Alexandra Le Duc-Pennec, Marie-Béatrice Cavarec, Rémi Marianovski, Pierre-Yves Salaün.   

Abstract

BACKGROUND: High tumor uptake of fluorodeoxyglucose (FDG) is associated with an unfavorable outcome in patients with cancer. We evaluated FDG uptake as a prognostic factor in patients with head and neck squamous cell carcinoma.
METHODS: Maximum standardized uptake values (SUVmax) of tumor, liver, and pulmonary artery were recorded. Ratios of SUVmax from tumor to liver (T/L) and from tumor to pulmonary artery (T/PA) were calculated for each patient. Clinical data, tumor, and SUVmax ratios were compared with disease-free survival (DFS) and overall survival (OS).
RESULTS: Eighty-nine patients were included: 48 presented a local recurrent disease or distant metastases and 42 died. For both DFS and OS, tumor SUVmax value of 7 was the best cutoff value and 4 and 5 for T/L and T/PA ratios. Multivariate analysis confirmed the independent prognostic value of these 3 thresholds for DFS and OS.
CONCLUSIONS: FDG uptake has a significant and independent relationship with recurrence and survival.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21604320     DOI: 10.1002/hed.21765

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

Review 1.  The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.

Authors:  Giovanni Cammaroto; Natale Quartuccio; Alessandro Sindoni; Francesca Di Mauro; Federico Caobelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

2.  Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma.

Authors:  Ronan Abgral; Nathalie Keromnes; Philippe Robin; Pierre-Yves Le Roux; David Bourhis; Xavier Palard; Jean Rousset; Gérald Valette; Rémi Marianowski; Pierre-Yves Salaün
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-07       Impact factor: 9.236

3.  Inter-observer and segmentation method variability of textural analysis in pre-therapeutic FDG PET/CT in head and neck cancer.

Authors:  Catherine Guezennec; David Bourhis; Fanny Orlhac; Philippe Robin; Jean-Baptiste Corre; Olivier Delcroix; Yves Gobel; Ulrike Schick; Pierre-Yves Salaün; Ronan Abgral
Journal:  PLoS One       Date:  2019-03-28       Impact factor: 3.240

4.  Influence of Semiquantitative [18F]FDG PET and Hematological Parameters on Survival in HNSCC Patients Using Neural Network Analysis.

Authors:  Paulina Cegla; Geoffrey Currie; Joanna P Wróblewska; Witold Cholewiński; Joanna Kaźmierska; Andrzej Marszałek; Anna Kubiak; Pawel Golusinski; Wojciech Golusiński; Ewa Majchrzak
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-14

5.  The Prognostic Role of Maximum Standardized Uptake Value of 18 F-FlouroDeoxy Glucose Positron Emission Tomography-Computed Tomography in Head and Neck Cancer Patients Undergoing Chemoradiotherapy.

Authors:  Kondaveeti Satish Srinivas; M Arunan; E Venkatachalapathy; Christopher John; M Manickavasagam; C V Divyambika
Journal:  J Int Soc Prev Community Dent       Date:  2019-04-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.